Amedisys Sustainability Profile
Amedisys, Inc., a leading provider of home health care and hospice services, is headquartered in the United States. Founded in 1982, the company has established a strong presence across various operational regions, focusing on delivering high-quality, patient-centred care. Amedisys offers a range of services, including skilled nursing, physical therapy, and hospice care, distinguished by its commitment to personalised treatment plans and innovative care solutions. With a reputation for excellence, Amedisys has achieved significant milestones, including recognition as one of the top home health care providers in the nation. The company’s dedication to improving patient outcomes and enhancing the quality of life positions it as a trusted leader in the home health industry, making it a preferred choice for families seeking compassionate care.
DitchCarbon Score
How does Amedisys's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amedisys's score of 31 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amedisys's reported carbon emissions
In 2021, Amedisys, headquartered in the US, reported total carbon emissions of approximately 49,980,400 kg CO2e. This figure includes Scope 1 emissions of about 12,517,600 kg CO2e, Scope 2 emissions of around 7,090,000 kg CO2e, and significant Scope 3 emissions totalling approximately 30,372,800 kg CO2e. The combined total of Scope 1 and Scope 2 emissions stands at about 19,607,600 kg CO2e. Amedisys's emissions data is cascaded from its parent company, Amedisys, Inc., which is part of a corporate family relationship with UnitedHealth Group Incorporated. However, there are currently no specific reduction targets or climate pledges disclosed by Amedisys, indicating a potential area for future commitment in climate action. The company’s emissions profile reflects the broader healthcare industry's challenges in managing carbon footprints, particularly in Scope 3 emissions, which often represent the largest share of total emissions. As Amedisys continues to navigate its environmental impact, further transparency and commitment to reduction initiatives may enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 12,517,600 |
| Scope 2 | 7,090,000 |
| Scope 3 | 30,372,800 |
How Carbon Intensive is Amedisys's Industry?
How Carbon Intensive is Amedisys's Location?
Amedisys's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amedisys has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
